HEADER TRANSFERASE/TRANSFERASE INHIBITOR 01-AUG-22 7YOL TITLE CRYSTAL STRUCTURE OF TETRA MUTANT (D67E, A68P, L98I, A301S) OF O- TITLE 2 ACETYLSERINE SULFHYDRYLASE FROM HAEMOPHILUS INFLUENZAE IN COMPLEX TITLE 3 WITH HIGH-AFFINITY INHIBITORY PEPTIDE OF SERINE ACETYLTRANSFERASE TITLE 4 FROM HAEMOPHILUS INFLUENZAE AT 2.4 A COMPND MOL_ID: 1; COMPND 2 MOLECULE: CYSTEINE SYNTHASE; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: CSASE,O-ACETYLSERINE (THIOL)-LYASE,OAS-TL,O-ACETYLSERINE COMPND 5 SULFHYDRYLASE,O-ACETYL-L-SERINE SULFHYDRYLASE; COMPND 6 EC: 2.5.1.47; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES; COMPND 9 MOL_ID: 2; COMPND 10 MOLECULE: PEPTIDE FROM SERINE ACETYLTRANSFERASE; COMPND 11 CHAIN: B; COMPND 12 SYNONYM: SAT; COMPND 13 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HAEMOPHILUS INFLUENZAE RD KW20; SOURCE 3 ORGANISM_TAXID: 71421; SOURCE 4 GENE: CYSK, HI_1103; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 MOL_ID: 2; SOURCE 8 SYNTHETIC: YES; SOURCE 9 ORGANISM_SCIENTIFIC: HAEMOPHILUS INFLUENZAE RD KW20; SOURCE 10 ORGANISM_TAXID: 71421 KEYWDS TETRA MUTANT (D67E, A68P, L98I, A301S), O-ACETYLSERINE SULFHYDRYLASE, KEYWDS 2 HAEMOPHILUS INFLUENZAE, HIGH-AFFINITY INHIBITORY PEPTIDE OF SERINE KEYWDS 3 ACETYLTRANSFERASE, TRANSFERASE, TRANSFERASE-TRANSFERASE INHIBITOR KEYWDS 4 COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR N.SAINI,N.KUMAR,R.RAHISUDDIN,A.K.SINGH REVDAT 1 02-AUG-23 7YOL 0 JRNL AUTH N.KUMAR,R.RAHISUDDIN,N.SAINI,A.K.SINGH JRNL TITL CRYSTAL STRUCTURE OF TETRA MUTANT (D67E, A68P, L98I, A301S) JRNL TITL 2 OF O-ACETYLSERINE SULFHYDRYLASE FROM HAEMOPHILUS INFLUENZAE JRNL TITL 3 IN COMPLEX WITH HIGH-AFFINITY INHIBITORY PEPTIDE FROM SERINE JRNL TITL 4 ACETYLTRANSFERASE OF HAEMOPHILUS INFLUENZAE AT 2.4 A JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 2.40 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0267 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.40 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 42.33 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 3 NUMBER OF REFLECTIONS : 11361 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : FREE R-VALUE REMARK 3 FREE R VALUE TEST SET SELECTION : NULL REMARK 3 R VALUE (WORKING + TEST SET) : NULL REMARK 3 R VALUE (WORKING SET) : 0.168 REMARK 3 FREE R VALUE : 0.197 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.141 REMARK 3 FREE R VALUE TEST SET COUNT : 584 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.50 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.53 REMARK 3 REFLECTION IN BIN (WORKING SET) : 768 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 100.0 REMARK 3 BIN R VALUE (WORKING SET) : 0.1880 REMARK 3 BIN FREE R VALUE SET COUNT : 44 REMARK 3 BIN FREE R VALUE : 0.2630 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2335 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 58 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 29.25 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -1.75700 REMARK 3 B22 (A**2) : -1.75700 REMARK 3 B33 (A**2) : 3.51300 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.579 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.227 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.153 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 6.489 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.951 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.940 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2370 ; 0.008 ; 0.012 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3212 ; 1.559 ; 1.633 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 310 ; 6.187 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 99 ;30.939 ;22.424 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 409 ;15.747 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 14 ;15.996 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 328 ; 0.112 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 1730 ; 0.008 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 1089 ; 0.212 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 1654 ; 0.303 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 107 ; 0.140 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1246 ; 2.318 ; 2.802 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 1554 ; 3.518 ; 4.184 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1124 ; 3.513 ; 3.046 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1658 ; 5.044 ; 4.394 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK BULK SOLVENT REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN USED IF PRESENT IN REMARK 3 THE INPUT FILE REMARK 4 REMARK 4 7YOL COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 16-AUG-22. REMARK 100 THE DEPOSITION ID IS D_1300030757. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 29-MAY-12 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.3-7.9 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.54179 REMARK 200 MONOCHROMATOR : MIRRORS REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MAR SCANNER 345 MM PLATE REMARK 200 INTENSITY-INTEGRATION SOFTWARE : IMOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 11361 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.400 REMARK 200 RESOLUTION RANGE LOW (A) : 42.330 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.5 REMARK 200 DATA REDUNDANCY : 15.50 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 126.4500 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.50 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.59 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 1Y7L REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 43.76 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.18 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1M HEPES, 1.3M SODIUM CITRATE, PH REMARK 280 7.5, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 278K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: I 41 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 3555 -Y,X+1/2,Z+1/4 REMARK 290 4555 Y+1/2,-X,Z+3/4 REMARK 290 5555 X+1/2,Y+1/2,Z+1/2 REMARK 290 6555 -X,-Y,Z REMARK 290 7555 -Y+1/2,X,Z+3/4 REMARK 290 8555 Y,-X+1/2,Z+1/4 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 56.18500 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 56.18500 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 22.85000 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 56.18500 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 11.42500 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 56.18500 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 34.27500 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 56.18500 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 56.18500 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 22.85000 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 7 0.000000 -1.000000 0.000000 56.18500 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 1.000000 34.27500 REMARK 290 SMTRY1 8 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 56.18500 REMARK 290 SMTRY3 8 0.000000 0.000000 1.000000 11.42500 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 5130 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 22660 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -27.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 GLU A 312 REMARK 465 GLY A 313 REMARK 465 ILE A 314 REMARK 465 GLU A 315 REMARK 465 GLY A 316 REMARK 465 ASP B 7 REMARK 465 GLY B 6 REMARK 465 MET B 5 REMARK 465 ASN B 4 REMARK 465 LEU B 3 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 SER A 301 OG REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 134 74.04 -154.58 REMARK 500 LYS A 142 73.17 73.72 REMARK 500 ASN A 149 -71.37 -62.78 REMARK 500 THR A 156 -70.85 -122.93 REMARK 500 REMARK 500 REMARK: NULL DBREF 7YOL A 1 316 UNP P45040 CYSK_HAEIN 1 316 DBREF 7YOL B 7 1 UNP P43886 CYSE_HAEIN 261 267 SEQADV 7YOL GLU A 67 UNP P45040 ASP 67 ENGINEERED MUTATION SEQADV 7YOL PRO A 68 UNP P45040 ALA 68 ENGINEERED MUTATION SEQADV 7YOL ILE A 98 UNP P45040 LEU 98 ENGINEERED MUTATION SEQADV 7YOL SER A 301 UNP P45040 ALA 301 ENGINEERED MUTATION SEQRES 1 A 316 MET ALA ILE TYR ALA ASP ASN SER TYR SER ILE GLY ASN SEQRES 2 A 316 THR PRO LEU VAL ARG LEU LYS HIS PHE GLY HIS ASN GLY SEQRES 3 A 316 ASN VAL VAL VAL LYS ILE GLU GLY ARG ASN PRO SER TYR SEQRES 4 A 316 SER VAL LLP CYS ARG ILE GLY ALA ASN MET VAL TRP GLN SEQRES 5 A 316 ALA GLU LYS ASP GLY THR LEU THR LYS GLY LYS GLU ILE SEQRES 6 A 316 VAL GLU PRO THR SER GLY ASN THR GLY ILE ALA LEU ALA SEQRES 7 A 316 TYR VAL ALA ALA ALA ARG GLY TYR LYS ILE THR LEU THR SEQRES 8 A 316 MET PRO GLU THR MET SER ILE GLU ARG LYS ARG LEU LEU SEQRES 9 A 316 CYS GLY LEU GLY VAL ASN LEU VAL LEU THR GLU GLY ALA SEQRES 10 A 316 LYS GLY MET LYS GLY ALA ILE ALA LYS ALA GLU GLU ILE SEQRES 11 A 316 VAL ALA SER ASP PRO SER ARG TYR VAL MET LEU LYS GLN SEQRES 12 A 316 PHE GLU ASN PRO ALA ASN PRO GLN ILE HIS ARG GLU THR SEQRES 13 A 316 THR GLY PRO GLU ILE TRP LYS ASP THR ASP GLY LYS VAL SEQRES 14 A 316 ASP VAL VAL VAL ALA GLY VAL GLY THR GLY GLY SER ILE SEQRES 15 A 316 THR GLY ILE SER ARG ALA ILE LYS LEU ASP PHE GLY LYS SEQRES 16 A 316 GLN ILE THR SER VAL ALA VAL GLU PRO VAL GLU SER PRO SEQRES 17 A 316 VAL ILE SER GLN THR LEU ALA GLY GLU GLU VAL LYS PRO SEQRES 18 A 316 GLY PRO HIS LYS ILE GLN GLY ILE GLY ALA GLY PHE ILE SEQRES 19 A 316 PRO LYS ASN LEU ASP LEU SER ILE ILE ASP ARG VAL GLU SEQRES 20 A 316 THR VAL ASP SER ASP THR ALA LEU ALA THR ALA ARG ARG SEQRES 21 A 316 LEU MET ALA GLU GLU GLY ILE LEU ALA GLY ILE SER SER SEQRES 22 A 316 GLY ALA ALA VAL ALA ALA ALA ASP ARG LEU ALA LYS LEU SEQRES 23 A 316 PRO GLU PHE ALA ASP LYS LEU ILE VAL VAL ILE LEU PRO SEQRES 24 A 316 SER SER SER GLU ARG TYR LEU SER THR ALA LEU PHE GLU SEQRES 25 A 316 GLY ILE GLU GLY SEQRES 1 B 7 ASP GLY MET ASN LEU ASN ILE MODRES 7YOL LLP A 42 LYS MODIFIED RESIDUE HET LLP A 42 24 HETNAM LLP (2S)-2-AMINO-6-[[3-HYDROXY-2-METHYL-5- HETNAM 2 LLP (PHOSPHONOOXYMETHYL)PYRIDIN-4- HETNAM 3 LLP YL]METHYLIDENEAMINO]HEXANOIC ACID HETSYN LLP N'-PYRIDOXYL-LYSINE-5'-MONOPHOSPHATE FORMUL 1 LLP C14 H22 N3 O7 P FORMUL 3 HOH *58(H2 O) HELIX 1 AA1 ASP A 6 ILE A 11 5 6 HELIX 2 AA2 LLP A 42 ASP A 56 1 15 HELIX 3 AA3 GLY A 71 GLY A 85 1 15 HELIX 4 AA4 SER A 97 LEU A 107 1 11 HELIX 5 AA5 GLU A 115 ALA A 117 5 3 HELIX 6 AA6 LYS A 118 ASP A 134 1 17 HELIX 7 AA7 PRO A 147 THR A 156 1 10 HELIX 8 AA8 THR A 156 THR A 165 1 10 HELIX 9 AA9 GLY A 179 ASP A 192 1 14 HELIX 10 AB1 PRO A 208 ALA A 215 1 8 HELIX 11 AB2 ASP A 239 ILE A 243 5 5 HELIX 12 AB3 ASP A 250 GLY A 266 1 17 HELIX 13 AB4 GLY A 270 LYS A 285 1 16 HELIX 14 AB5 LEU A 286 ALA A 290 5 5 HELIX 15 AB6 SER A 301 LEU A 306 5 6 SHEET 1 AA1 6 LEU A 16 ARG A 18 0 SHEET 2 AA1 6 VAL A 28 ILE A 32 -1 O VAL A 30 N VAL A 17 SHEET 3 AA1 6 LEU A 293 LEU A 298 1 O VAL A 296 N LYS A 31 SHEET 4 AA1 6 VAL A 169 GLY A 175 1 N VAL A 171 O VAL A 295 SHEET 5 AA1 6 THR A 198 PRO A 204 1 O VAL A 200 N VAL A 172 SHEET 6 AA1 6 ARG A 245 VAL A 249 1 O GLU A 247 N ALA A 201 SHEET 1 AA2 4 ASN A 110 THR A 114 0 SHEET 2 AA2 4 ILE A 88 PRO A 93 1 N ILE A 88 O ASN A 110 SHEET 3 AA2 4 GLU A 64 GLU A 67 1 N ILE A 65 O THR A 89 SHEET 4 AA2 4 TYR A 138 VAL A 139 1 O VAL A 139 N VAL A 66 LINK C VAL A 41 N LLP A 42 1555 1555 1.35 LINK C LLP A 42 N CYS A 43 1555 1555 1.33 CRYST1 112.370 112.370 45.700 90.00 90.00 90.00 I 41 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.008899 0.000000 0.000000 0.00000 SCALE2 0.000000 0.008899 0.000000 0.00000 SCALE3 0.000000 0.000000 0.021882 0.00000